Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy.
about
Why is diabetes mellitus a risk factor for contrast-induced nephropathy?Side effects of radiographic contrast media: pathogenesis, risk factors, and preventionRadiographic contrast-media-induced acute kidney injury: pathophysiology and prophylactic strategiesAcute kidney injury by radiographic contrast media: pathogenesis and prevention.Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback.Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.Contrast-induced nephropathy--a review of current literature and guidelines.Nephroprotective potential of carnitine against glycerol and contrast-induced kidney injury in rats through modulation of oxidative stress, proinflammatory cytokines, and apoptosisIodinated contrast media can induce long-lasting oxidative stress in hemodialysis patientsADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiographyPathophysiology of renal tissue damage by iodinated contrast media.Contrast-induced kidney injury: mechanisms, risk factors, and prevention.Cellular adaptive changes in AKI: mitigating renal hypoxic injury.Contrast-induced acute kidney injury: how much contrast is safe?Contrast media viscosity versus osmolality in kidney injury: lessons from animal studies.Molecular mechanisms of renal cellular nephrotoxicity due to radiocontrast mediaLong-Term Follow-Up of Patients at High Risk for Nephropathy After Contrast Exposure.Intravascular radiocontrast iodixanol increases permeability of proximal tubule epithelium: a possible mechanism of contrast-induced nephropathy.Understanding and preventing contrast-induced acute kidney injury.Contrast-induced acute kidney injury: A review of practical points.Update on the renal toxicity of iodinated contrast drugs used in clinical medicine.Sildenafil prevents renal dysfunction in contrast media-induced nephropathy in Wistar rats.In Vivo Imaging of Intraocular Fluidics in Vitrectomized Swine Eyes Using a Digital Fluoroscopy System.Medullary thick ascending limb buffer vasoconstriction of renal outer-medullary vasa recta in salt-resistant but not salt-sensitive rats.Simvastatin attenuates contrast-induced nephropathy through modulation of oxidative stress, proinflammatory myeloperoxidase, and nitric oxide.Contrast-induced nephropathy: pharmacology, pathophysiology and prevention.Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.Early effects of an x-ray contrast medium on renal T(2) */T(2) MRI as compared to short-term hyperoxia, hypoxia and aortic occlusion in rats.Functional characterization of isolated, perfused outermedullary descending human vasa recta.Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta.
P2860
Q26821989-AC581EF3-B0B0-4E51-B4D4-8434AB28CDBEQ26853304-B66EF658-6D7F-4B8D-AC12-07134D18CDA0Q27021421-7BAF9040-1E91-44E9-AF7B-9A9D9DDCCA4EQ34114127-7258C644-B6A4-495D-BFCB-8C86A5331F5BQ35576454-811F1662-6CA6-4867-B30F-C126B101358DQ35930002-9A6D5023-ED04-42DF-B18A-8F81D2C89EB7Q36576632-F6966933-2960-4F8F-AE5D-C512EAB3ADEEQ37175582-0C54099C-50DF-4BBC-8EA6-B1CCE46657EFQ37259512-E112BEDA-1D80-411E-B763-EBE18642F088Q37646687-0E16CBFD-7CDA-44AA-B8E2-2598ED6D4EE1Q37846792-E2B8E924-E70E-4C61-8301-C01926C95F96Q37977872-D8F98560-53C9-459F-A3D1-7FA951EA51E2Q38006680-145E5B0B-7DDD-42CA-8C54-144628112FBBQ38081850-2EAC2217-3B34-4F43-96F1-6DB3092AA4F6Q38202647-800DA002-B66E-4148-99D8-BA525FE5A37FQ38205449-14BCF3C6-E038-430B-86BD-7529D0E456D0Q38239224-CB7AE522-7BBA-4024-BFE3-7FEB655ADFA1Q39100224-5F7A5759-9C80-4F6F-AF75-53CC4D530121Q39110308-6C5BD3EF-F6C0-40B1-8E45-A546D69FB1DEQ39327802-A735713F-7CEC-44D7-A2C2-1893D97709DAQ39349844-6DDF93BC-AA77-484F-97A9-59CAED065861Q40082063-FABA5650-57B7-4373-82C0-D65E5ECAE059Q40260110-291B5850-5358-4FCA-80E7-A917376F2511Q42026926-4BAD77CA-BEEB-4A5C-87B8-F8FAA5E16786Q42418082-09B7F97B-D5E4-4441-A9C4-390DCD9450F7Q42854993-7FA9C020-4078-494B-91B4-7ECD32FEA60FQ50992674-69E764B6-7A02-4974-B0A6-0E0293A857F7Q52884622-9314E65C-05C7-47E3-B57A-EE9E851F8DDCQ52884862-F4D0F5FF-A243-459D-A9CA-1D837155B2D4Q52886371-81C82279-28B3-4417-A721-F30398BB4EB5
P2860
Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Iodixanol, constriction of med ...... st medium-induced nephropathy.
@ast
Iodixanol, constriction of med ...... st medium-induced nephropathy.
@en
type
label
Iodixanol, constriction of med ...... st medium-induced nephropathy.
@ast
Iodixanol, constriction of med ...... st medium-induced nephropathy.
@en
prefLabel
Iodixanol, constriction of med ...... st medium-induced nephropathy.
@ast
Iodixanol, constriction of med ...... st medium-induced nephropathy.
@en
P2093
P2860
P1433
P1476
Iodixanol, constriction of med ...... st medium-induced nephropathy.
@en
P2093
A Erik Persson
Andreas Patzak
Chunhua Cao
Mauricio Sendeski
Pontus B Persson
Thomas L Pallone
P2860
P304
P356
10.1148/RADIOL.2513081732
P407
P577
2009-04-14T00:00:00Z